FDA 483 - NATCO Pharma Limited Chemical Division Chennai - November 21, 2025

I am unable to create a concise summary of the FDA 483 document as the provided content indicates that the document is empty or contains no readable text. To fulfill this request, please provide the complete text of the inspection report, including details such as the company name, inspection dates, main violations or issues observed, the relevant regulatory framework, and any required actions. Once the content is available, I can generate a professional summary within the specified word count.